Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing

Filed Under: Pharma Tagged With: , , , , , ,

Sumitomo Chemical Co. Ltd. (TYO:4005) is looking to establish a new plant for the mass production of single-guide RNA, a…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
Sumitomo Chemical Pursues Genome Editing for Agricultural Cultivation
Sumitomo Chemical Pursues Genome Editing for…
Sumitomo Chemical Highlights Four Areas for R&D Focus Under New Corporate Plan
Sumitomo Chemical Highlights Four Areas for R&D…
Chemical and Materials Companies Plan Further Initiatives for Health Care Sector
Chemical and Materials Companies Plan Further…
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Eyes Mass Production of…
Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals
Japan Looks to Catch the West as Opportunities Open…